Form 4 Tracker
Keros Therapeutics, Inc.
KROS

10 insider filings · Latest: Jun 4, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 4, 2026Jun 5 4:15 PMAlpna SethDirector
Sale
2,625$10.72$28.1K9,767(D)

View →

May 15, 2026May 19 4:15 PMJean Jacques BienaimeDirector
Purchase
1,000$10.58$10.6K9,450(D)

View →

Apr 15, 2026Apr 17 4:15 PMJean Jacques BienaimeDirector
Purchase
1,000$11.70$11.7K8,450(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 3, 2026Jun 5 5:20 PMAlpna SethDirector
Grant/Award
7,433$10.507,433(D)

View →

Jun 3, 2026Jun 5 4:15 PMMary Ann GrayDirector
Grant/Award
7,433$10.507,433(D)

View →

Jun 3, 2026Jun 5 4:15 PMNima FarzanDirector
Grant/Award
7,433$10.507,433(D)

View →

Jun 3, 2026Jun 5 4:15 PMJean Jacques BienaimeDirector
Grant/Award
7,433$10.507,433(D)

View →

Jun 3, 2026Jun 5 4:15 PMJulius KnowlesDirector
Grant/Award
7,433$10.507,433(D)

View →

Apr 2, 2026Apr 6 4:15 PMJasbir SeehraDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
55,000$0.30197,444(D)

View →

Feb 24, 2026Mar 27 4:15 PMEsther ChoChief Legal Officer
Grant/Award
80,000$15.5280,000(D)

View →